RAFAEL HOLDINGS, INC. Gain (Loss) on Investments
RAFAEL HOLDINGS, INC. (RFL) reported Gain (Loss) on Investments of -$46.00 thousand for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2025-03-14
- RAFAEL HOLDINGS, INC. gain (loss) on investments for the quarter ending 2024-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for the quarter ending 2023-10-31 was -$46.00K.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for the quarter ending 2019-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for the quarter ending 2019-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for fiscal 2024 was -$46.00K.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for fiscal 2019 was $330.00K, a 2650.00% increase from fiscal 2018.
- RAFAEL HOLDINGS, INC. gain (loss) on investments for fiscal 2018 was $12.00K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2024-07-31 | -$46.00K 10-K/A · filed 2024-12-20 | |||
| 2024-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$46.00K 10-Q · filed 2025-03-14 | ||
| 2023-10-31 | -$46.00K 10-Q · filed 2024-12-11 | |||
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $0.00 derived: sum of 2 quarters · filed 2019-10-04 | $103.00K derived: sum of 3 quarters · filed 2019-10-04 | $330.00K 10-K · filed 2019-10-04 |
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $103.00K derived: sum of 2 quarters · filed 2019-06-05 | $330.00K 10-Q · filed 2019-06-05 | $81.00K derived: sum of 4 quarters · filed 2019-10-04 |
| 2019-01-31 | $103.00K 10-Q · filed 2019-03-12 | $330.00K 10-Q · filed 2019-03-12 | $81.00K derived: sum of 3 quarters · filed 2019-10-04 | $105.00K derived: sum of 4 quarters · filed 2019-10-04 |
| 2018-10-31 | -$10.00K 10-Q · filed 2018-12-10 | -$22.00K derived: sum of 2 quarters · filed 2019-10-04 | $2.00K derived: sum of 3 quarters · filed 2019-10-04 | |
| 2018-07-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $12.00K derived: sum of 2 quarters · filed 2019-10-04 | $12.00K 10-K · filed 2019-10-04 | |
| 2018-04-30 | $24.00K 10-Q · filed 2019-06-05 | $24.00K 10-Q · filed 2019-06-05 | ||
| 2017-04-30 | $167.00K 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |